Suven Life Sciences informs about monitoring agency report

09 Feb 2023 Evaluate
Pursuant to Regulation 82(4) of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018 and Regulation 32 (6) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Life Sciences has informed that it enclosed the Monitoring Agency Report with respect to utilization of proceeds of the Rights Issue of the Company for the quarter ended on December 31, 2022, issued by CRISIL Ratings, Monitoring Agency.

The above information is a part of company’s filings submitted to BSE.

Suven Life Sciences Share Price

168.00 -1.35 (-0.80%)
11-Dec-2025 09:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.00
Dr. Reddys Lab 1256.85
Cipla 1496.75
Zydus Lifesciences 922.70
Lupin 2053.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×